Silver Book Fact

Tools to Prevent Secondary Osteoporosis Fractures are Not Being Used

Fact image

Hansen D, Bazell C, Pelizzari P, Pyenson B. Medicare Cost of Osteoporotic Fractures. Milliman Research Report. 2019; https://static1.squarespace.com/static/5c0860aff793924efe2230f3/t/5d76b949deb7e9086ee3d7dd/1568061771769/Medicare+Cost+of+Osteoporotic+Fractures+20190827.pdf

Reference

Title
Medicare Cost of Osteoporotic Fractures
Publication
Milliman Research Report
Publication Date
2019
Authors
Hansen D, Bazell C, Pelizzari P, Pyenson B
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value
  • Economic Value
  • Future Value

Related Facts

  • Ibandronate, a bisphosphonate, taken daily has been shown to reduce the risk of new vertebral fractures by around 62%.  
  • An Alzheimer’s disease treatment breakthrough that slowed its progression and began to show its effects in 2015, would reduce the costs of care for all people with the disease by…  
  • Risedronate, a bisphosphonate, has been shown to reduce vertebral fractures by around 41%, hip fractures by 30%, and non-vertebral fractures by 39%.  
  • Teriparatide, or human recombinant PTH, has been shown to decrease vertebral fractures by 65% to 69%, and non-vertebral fragility fractures by around 53%.  
  • The Study of Osteoporotic Fractures, which began over 20 years ago, found that bone mineral density (BMD) of the hip is one of the best predictors of fracture for women,…